$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole

New Post Public Reply Private Reply Replies (1) Message Board
AAAAMHIM zigzagman #17692
$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole country. THE BEST PENNYSTOCK IN America, and COULD BE THE pharmacy stock of the year. This stock can run 30,000% here's why.

1) EXTREMELY OVERSOLD and unknown 
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. 
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
4) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
5) WON AWARD FOR THEIR DRUG
6) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
7) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
8) THEY HAVE A PATENT which big boys have to be eyeing.

FELLAS PLEASE...PLEASE DO SOME RESEARCH ON THIS DRUG. VDRM IS A HIDDEN GOLDMINE

Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.
Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity.
Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.

Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014

Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.
Ability to enable active ingredients with a rapid transport direct to the site of action.

Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.
Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher. 


VDRM transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City
Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC. 

Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing. 

THIS IS NOT A REGULAR PENNY STOCK fellas. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHEST percentage gain in big boards or penny stocks.


Look at their product. LOOK AT WHAT THIS DRUG CAN DO! This is liquid gold IMO. The drug is unknown the stock is unknown but not for long http://www.viadermalicensing.com/img/ViaDermaCaseStudies.pdf
Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Long March: Legacy Shaping a New Era

Updated Category News Views 0

The Enduring Spirit of the Long March Remember the original Long March? Two years, 25,000 li, and countless struggles. It was more than a military campaign—it was a flame of hope burning in the bleakest of times. Even today, folks in China still nod to its spirit as they navigate the nation's economic and social landscape. You might ask, "Why hold onto an event from 90...

Continue Reading
Watchtower Labs: New Era of AI in Military Ops

Updated Category News Views 15

Big Moves in Military Planning Alright, folks, here's the skinny on something that's bound to shake up the military sector: Watchtower Labs has kicked the door open after its stealthy beginnings with a hefty $35 million in seed funding. Investors like Shield Capital, Conviction, and Founders Fund are throwing their weight behind this AI-powered venture that's poised to...

Continue Reading
Trimble's AI Boosts Construction Risk Management

Updated Category News Views 9

Navigating Construction's Risky Waters La-di-da, another day, another dollar lost—or won—in the construction zone. But hey, here comes Trimble waving a shiny new AI-driven flag that promises to shut down those wrench-tossing surprises in construction projects. They're calling it the Document Crunch, a tool that lets contractors review everything from drawings to...

Continue Reading
Cystic Fibrosis Market: Emerging Therapies Boost Growth

Updated Category News Views 4

The landscape of cystic fibrosis treatment is on the cusp of a seismic shift, promising new therapies poised to redefine patient care and market dynamics. As we stand at the intersection of innovation and opportunity, the impending transformation is fueled by groundbreaking therapies, increased healthcare spending, and a stronger push for personalized medicine. The Winds...

Continue Reading
Trilogy Metals Advances Arctic Project's Potential

Updated Category News Views 5

Trilogy Metals Completes Ambler Metals Field Work Alright, folks, let's dive into a mining story that should catch the discerning eye. Trilogy Metals (NYSE: TMQ) proudly wrapped up its 2026 field season at the Upper Kobuk Mineral Projects (UKMP), located in northwestern Alaska. And if you're neck-deep in the mining sector, this isn't just a thing on the periphery; it's a...

Continue Reading
How Track Rabbit Levels the Playing Field for Small Motorsport Ventures

Updated Category News Views 3

Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...

Continue Reading
ILS and Anduin Join Forces to Streamline Fundraising

Updated Category News Views 3

Big Moves in Legal Tech and Fundraising In the world of investing, where technology is always a step ahead, Intelligent Legal Solutions (ILS) and Anduin are cooking up a storm with their latest partnership announcement. Targeting private markets fund managers and law firms, these two tech players aim to ease the layered chaos that comes with fundraising by integrating...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 5

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
Vermilion Energy Sets Dates for Earnings and Calls

Updated Category News Views 5

The Anticipation Around Vermilion's Upcoming Results There's a buzz in the air about Vermilion Energy Inc.'s upcoming Q3 2026 financial results. Slated to hit the wires November 4th, before the sun rises on Wall Street, folks in the trade have their eyes peeled to parse through any morsels of data. The question on everyone's mind? Whether they're making the right moves to...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 4

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Growth: The Vanguard Mega Cap Growth ETF Opportunity

Updated Category News Views 213

The S&P 500 isn’t just a bunch of random stocks; it’s home to about 500 companies where the heavyweights like Apple, Nvidia, and Microsoft play a huge role. Back then, these tech titans held a jaw-dropping market cap of around $9.8 trillion—yeah, that's about 19.7% of the entire S&P 500! You could practically feel the desks humming with excitement as Nvidia...

Continue Reading
Celsius Holdings, Inc. Faces Class Action: Investors Invited to Lead

Updated Category News Views 327

Class Action Lawsuit Overview Against Celsius Holdings, Inc. Celsius Holdings, Inc. (NASDAQ: CELH), known for its innovative energy drinks and liquid supplements, is currently facing a class action lawsuit. This legal action arises from significant allegations regarding misleading financial statements and substantial losses suffered by investors during a defined Class...

Continue Reading
Cellectar Biosciences Strategizes for Future Growth Opportunities

Updated Category News Views 146

Exploring Strategic Alternatives for Growth Cellectar Biosciences, Inc. (NASDAQ: CLRB) is embarking on a thoughtful exploration of various strategic alternatives aimed at enhancing its innovative drug development pipeline and maximizing stockholder value. While the specific alternatives remain under consideration, possibilities could include mergers, acquisitions, and...

Continue Reading
Wells Fargo Initiates Buy Rating on The Trade Desk Amid Growth Prospects

Updated Category News Views 29

Wells Fargo Issues Buy Rating for The Trade Desk Wells Fargo has recently begun its coverage of The Trade Desk (NASDAQ: TTD) with a favorable Buy rating, aiming for a price target of $150. This comes in anticipation of the company’s upcoming quarterly earnings report. Analysts are upbeat about the prospects due to a multitude of factors that are expected to play a...

Continue Reading
Vulcan V-PRO FLIGHT: A Game-Changer for Pickleball Events

Updated Category News Views 232

Vulcan V-PRO FLIGHT: Official Ball of DUPR The world of pickleball is experiencing a transformative partnership as the Vulcan V-PRO FLIGHT has been recognized as the Official Ball of DUPR (Dynamic Universal Pickleball Rating). This landmark decision encompasses all DUPR events, ensuring that the Vulcan ball will be used across various leagues, tournaments, clubs, and...

Continue Reading